Kenneth J. Hillan - May 20, 2023 Form 4 Insider Report for 23andMe Holding Co. (ME)

Role
Chief Therapeutics Officer
Signature
/s/ Kenneth Hillan, by Kathy Hibbs, attorney-in-fact
Stock symbol
ME
Transactions as of
May 20, 2023
Transactions value $
-$8,978
Form type
4
Date filed
5/23/2023, 04:05 PM
Previous filing
Feb 22, 2023
Next filing
Jun 5, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ME Class A Common Stock Tax liability -$8.98K -4.63K -2.34% $1.94 193K May 20, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The closing price on May 19, 2023, the fair market value used for the transaction date.
F2 Includes 5,765 shares acquired under the 23andMe Holding Co. 2021 Employee Stock Purchase Plan on February 28, 2023.